Profilo
Denis G.
Kay is the founder.
He founded Alpha Cognition, Inc. in 2000, where he currently holds the title of Chief Scientific Officer.
He also founded Neurodyn Life Sciences, Inc. in 2006, where he currently holds the title of Chief Scientific Officer.
Dr. Kay's former job was at Neurodyn, Inc., where he held the title of Director & Chief Scientific Officer.
Dr. Kay's education includes a doctorate degree from McGill University and undergraduate and graduate degrees from Dalhousie University.
Posizioni attive di Denis G. Kay
| Società | Posizione | Inizio |
|---|---|---|
| ALPHA COGNITION INC. | Fondatore | 01/01/2000 |
Neurodyn Life Sciences, Inc.
 Neurodyn Life Sciences, Inc. BiotechnologyHealth Technology Neurodyn Life Sciences, Inc. engages in identifying, validating, and developing natural bioactives for the early treatment of neurological diseases. The private company is based in Vancouver, Canada. The Canadian company was founded by Kenneth A. Cawkell, who has been the CEO since incorporation. | Fondatore | 01/08/2006 |
Precedenti posizioni note di Denis G. Kay
| Società | Posizione | Fine |
|---|---|---|
Neurodyn, Inc.
 Neurodyn, Inc. Pharmaceuticals: MajorHealth Technology Neurodyn, Inc. provides neurological diseases detection. It discovers and develops bioactive compounds into treatments for neurological diseases. The company was founded by Christopher A. Shaw in 2013 and is headquartered in Charlottetown, PA. | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Denis G. Kay
| Dalhousie University | Graduate Degree |
| McGill University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ALPHA COGNITION INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Neurodyn, Inc.
Neurodyn, Inc. Pharmaceuticals: MajorHealth Technology Neurodyn, Inc. provides neurological diseases detection. It discovers and develops bioactive compounds into treatments for neurological diseases. The company was founded by Christopher A. Shaw in 2013 and is headquartered in Charlottetown, PA. | Health Technology |
Neurodyn Life Sciences, Inc.
Neurodyn Life Sciences, Inc. BiotechnologyHealth Technology Neurodyn Life Sciences, Inc. engages in identifying, validating, and developing natural bioactives for the early treatment of neurological diseases. The private company is based in Vancouver, Canada. The Canadian company was founded by Kenneth A. Cawkell, who has been the CEO since incorporation. | Health Technology |
- Borsa valori
- Insiders
- Denis G. Kay
